Cargando…
Hypercoagulable State and Thrombosis of Bioprosthetic Transcatheter Aortic Valve Replacement (TAVR) Refractory to Common Anticoagulation Methods in the Setting of Protein S Deficiency
Protein S deficiency is a form of thrombophilia in which the anticoagulant protein S is underproduced or not produced at all by the body. Lifelong anticoagulation is the mainstay of treatment. Transcatheter aortic valve replacement (TAVR) is a current treatment modality for patients with severe aort...
Autores principales: | Kellam, Caleb J, Derraj, Jurxhin, Furletti, Gregory M, Ren, Bibai, Patel, Toral |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249060/ https://www.ncbi.nlm.nih.gov/pubmed/37303358 http://dx.doi.org/10.7759/cureus.38754 |
Ejemplares similares
-
Marked changes in bioprosthetic valve thrombosis by anticoagulation therapy
por: Takasaki, Akihiro, et al.
Publicado: (2019) -
Thrombolysis for Cardiogenic Shock Secondary to Aortic Bioprosthetic Valve-in-Valve Thrombosis
por: Chu, Jian, et al.
Publicado: (2022) -
Association Between Body Mass Index and Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement (TAVR) with Edwards SAPIEN™ 3 TAVR Valves: A Single-Center Experience
por: Ahmad, Mansoor, et al.
Publicado: (2019) -
Premature Bioprosthetic Mitral Valve Dysfunction Due to Flail Leaflet Treated With Transcatheter Mitral Valve Replacement; a Case Report
por: Munoz, Carlos, et al.
Publicado: (2022) -
Commensal Streptococcal Infective Endocarditis of the Native Mitral Valve in a Transcatheter Aortic Valve Replacement (TAVR) Patient: A Heartful, a Handful, and a Mouthful
por: Kozak, Michael, et al.
Publicado: (2023)